BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19644876)

  • 21. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
    Avcin T; Silverman ED
    Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cigarette smoking, STAT4 and TNFRSF1B polymorphisms, and systemic lupus erythematosus in a Japanese population.
    Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Atsumi T; Kobashi G; Takahashi H;
    J Rheumatol; 2009 Oct; 36(10):2195-203. PubMed ID: 19684152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms in TNFAIP3, but not in STAT4, BANK1, BLK, and TNFSF4, are associated with susceptibility to Takayasu arteritis.
    Montúfar-Robles I; Soto ME; Jiménez-Morales S; Gamboa R; Huesca-Gómez C; Ramírez-Bello J
    Cell Immunol; 2021 Jul; 365():104375. PubMed ID: 33975174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus.
    Kozyrev SV; Abelson AK; Wojcik J; Zaghlool A; Linga Reddy MV; Sanchez E; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Pons-Estel BA; Witte T; D'Alfonso S; Barizzone N; Danieli MG; Gutierrez C; Suarez A; Junker P; Laustrup H; González-Escribano MF; Martin J; Abderrahim H; Alarcón-Riquelme ME
    Nat Genet; 2008 Feb; 40(2):211-6. PubMed ID: 18204447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE).
    Demirci FY; Manzi S; Ramsey-Goldman R; Minster RL; Kenney M; Shaw PS; Dunlop-Thomas CM; Kao AH; Rhew E; Bontempo F; Kammerer C; Kamboh MI
    Ann Hum Genet; 2007 May; 71(Pt 3):308-11. PubMed ID: 17166181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BLK and BANK1 polymorphisms and interactions are associated in Mexican patients with systemic lupus erythematosus.
    Ramírez-Bello J; Jiménez-Morales S; Montufar-Robles I; Fragoso JM; Barbosa-Cobos RE; Saavedra MA; Sánchez-Muñoz F
    Inflamm Res; 2019 Aug; 68(8):705-713. PubMed ID: 31134304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meta-analysis of the association of IRF5 polymorphism with systemic lupus erythematosus.
    Hu W; Ren H
    Int J Immunogenet; 2011 Oct; 38(5):411-7. PubMed ID: 21834935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of HLA-DM polymorphism with the production of antiphospholipid antibodies.
    Sanchez ML; Katsumata K; Atsumi T; Romero FI; Bertolaccini ML; Funke A; Amengual O; Kondeatis E; Vaughan RW; Cox A; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2004 Dec; 63(12):1645-8. PubMed ID: 15547089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.
    Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population.
    Shimane K; Kochi Y; Yamada R; Okada Y; Suzuki A; Miyatake A; Kubo M; Nakamura Y; Yamamoto K
    Ann Rheum Dis; 2009 Mar; 68(3):377-83. PubMed ID: 18408250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome.
    Nordmark G; Kristjansdottir G; Theander E; Appel S; Eriksson P; Vasaitis L; Kvarnström M; Delaleu N; Lundmark P; Lundmark A; Sjöwall C; Brun JG; Jonsson MV; Harboe E; Gøransson LG; Johnsen SJ; Söderkvist P; Eloranta ML; Alm G; Baecklund E; Wahren-Herlenius M; Omdal R; Rönnblom L; Jonsson R; Syvänen AC
    Genes Immun; 2011 Mar; 12(2):100-9. PubMed ID: 20861858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population.
    Järvinen TM; Hellquist A; Zucchelli M; Koskenmies S; Panelius J; Hasan T; Julkunen H; D'Amato M; Kere J
    Rheumatology (Oxford); 2012 Jan; 51(1):87-92. PubMed ID: 22039224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases.
    Martínez A; Varadé J; Márquez A; Cénit MC; Espino L; Perdigones N; Santiago JL; Fernández-Arquero M; de la Calle H; Arroyo R; Mendoza JL; Fernández-Gutiérrez B; de la Concha EG; Urcelay E
    Arthritis Rheum; 2008 Sep; 58(9):2598-602. PubMed ID: 18759272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis.
    Karassa FB; Bijl M; Davies KA; Kallenberg CG; Khamashta MA; Manger K; Michel M; Piette JC; Salmon JE; Song YW; Tsuchiya N; Yoo DH; Ioannidis JP
    Arthritis Rheum; 2003 Jul; 48(7):1930-8. PubMed ID: 12847687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epistatic interaction between BANK1 and BLK in rheumatoid arthritis: results from a large trans-ethnic meta-analysis.
    Génin E; Coustet B; Allanore Y; Ito I; Teruel M; Constantin A; Schaeverbeke T; Ruyssen-Witrand A; Tohma S; Cantagrel A; Vittecoq O; Barnetche T; Le Loët X; Fardellone P; Furukawa H; Meyer O; Fernández-Gutiérrez B; Balsa A; González-Gay MA; Chiocchia G; Tsuchiya N; Martin J; Dieudé P
    PLoS One; 2013; 8(4):e61044. PubMed ID: 23646104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
    Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.